Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$17,260,742
+$2,334,404 QoQ
Shares Held
68,593
-0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#675
of 4,150 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ST GERMAIN D J CO INC holds $99,025,710 across 15 Drug Manufacturers - General names. ABBV ranks #3 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
146,636 | $37,241,144 | |
| 2 | AMGN |
Amgen Inc
|
83,929 | $30,392,369 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
68,593 | $17,260,742 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,096 | $4,895,336 | |
| 5 | NVO |
Novo Nordisk A S
|
78,302 | $3,753,797 | |
| 6 | LLY |
ELI LILLY & Co
|
1,756 | $2,106,199 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,453 | $1,005,641 | |
| 8 | NVS |
Novartis AG
|
6,177 | $968,059 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,260,742 | 68,593 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $14,926,338 | 68,630 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $15,723,082 | 68,813 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $15,850,070 | 68,455 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $12,625,686 | 68,019 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $13,975,822 | 66,704 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $12,102,791 | 68,108 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $13,341,748 | 67,560 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $11,567,994 | 67,444 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $12,303,040 | 67,562 | Shares | Sole | 2024-04-02 | |
| 2023-12-31 | $10,417,393 | 67,222 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $9,745,691 | 65,381 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $9,567,581 | 71,013 | Shares | Sole | 2023-09-07 | |
| 2022-12-31 | $21,123,719 | 130,708 | Shares | Sole | 2023-02-27 | |
| 2022-09-30 | $9,613,596 | 71,631 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $10,971,003 | 71,631 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,564,116 | 71,335 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,948,985 | 80,864 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,227,676 | 76,274 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $8,775,219 | 77,905 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $8,417,351 | 77,780 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,646,224 | 71,360 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $6,181,138 | 70,569 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $7,005,633 | 71,355 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,436,385 | 71,353 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||